关键词: SCN5A Mechanisms NaV1.5 Sodium channelopathies Therapies
Mesh : Action Potentials / drug effects Animals Anti-Arrhythmia Agents / therapeutic use Arrhythmias, Cardiac / drug therapy genetics metabolism physiopathology Channelopathies / drug therapy genetics metabolism physiopathology Genetic Predisposition to Disease Heart Rate / drug effects Heredity Humans Mutation Myocytes, Cardiac / drug effects metabolism NAV1.5 Voltage-Gated Sodium Channel / drug effects genetics metabolism Phenotype Risk Factors Voltage-Gated Sodium Channel Blockers / therapeutic use
来 源:
DOI:10.1093/cvr/cvaa082
PDF(Sci-hub)
PDF(Pubmed)